NEW PROVIDENCE, NJ, Coronary stent maker Svelte Medical Systems Inc. raised $9.69 million of a targeted $12 million in a mixed securities offering. The firm has raised money from Apjohn, Norwich, and CNF in past fund raisings.

The offering, which originated in October of 2010, first established a goal of $6 million and launched with $4.49 million.

Dr.'s Robert, David and Tim Fischell founded Svelte in 2007 with the mission to address key clinical issues in the cardiovascular stent market by improving stent deliverability, reducing procedural time and costs and improving safety. The Fischells bring their tremendous knowledge of stent design and incredible entrepreneurial experience to the company. Collectively, they have over 200 patents associated with medical devices and have created over 14 medical related companies in the past twenty years.